reports
Due to a more favourable environment, MENICON slightly increases to Ne...
MENICON (JP), a company active in the Medical Equipment industry, slightly increases its general evaluation. The independent financial analyst theScreener just confirmed the stock market behaviour of the title as moderately risky. At the fundamental level, theScreener confirms the rating of 1 out of 4 stars; given the more favourable environment, the title's overall rating is upgraded to Neutral even if it remains under pressure. As of the analysis date October 26, 2021, the closing price was JP...
- Dave Nicoski
- Ross LaDuke
Vermilion Int'l Compass: Global Equity Strategy
Mixed Market Environment Continues The Hang Seng, EURO STOXX 50, MSCI ACWI ex-US, and MSCI EAFE display bearish short-term inflections. Additionally, 10-year yields in the US and Germany are breaking down below key support. These deteriorating market dynamics raise concerns of a deeper pullback, however other indicators remain largely positive. As a result, we continue to see a mixed, but overall constructive market. Index Overviews. Some indexes are beginning to deteriorate while others remai...
- Dave Nicoski
- Ross LaDuke
Vermilion Int'l Compass: Global Equity Strategy
Health Care Hitting On All Cylinders Global equities remain in a short-term consolidation phase, however we continue to believe the longer-term trend is up and to the right for the MSCI ACWI following the late-October breakout... see chart below. • Market Ignoring Negative Headlines. Global equity markets continue to generally shrug off seemingly bearish headlines surrounding trade, Trump impeachment hearings, and ongoing protests in Hong Kong. This tells us that the good outweighs the bad i...
FME FRESENIUS MEDICAL CARE AG
UNJ UNITED LABORATORIES INTERNATIONAL HOLDINGS LTD.
300482 GUANGZHOU WONDFO BIOTECH CO. LTD. CLASS A
AFX CARL ZEISS MEDITEC AG
EUROFINS SCIENTIFIC SOCIETE EUROPEENNE
FRE FRESENIUS SE & CO. KGAA
BAYN BAYER AG
GEN GENMAB A/S
600763 TOPCHOICE MEDICAL CORP. CLASS A
COH COCHLEAR LIMITED
600276 JIANGSU HENGRUI MEDICINE CO. LTD. CLASS A
4530 HISAMITSU PHARMACEUTICAL CO. INC.
4521 KAKEN PHARMACEUTICAL CO. LTD.
002007 HUALAN BIOLOGICAL ENGINEERING INC. CLASS A
FLRY3 FLEURY SA
7780 MENICON
4544 H.U.GROUP HOLDINGS INC.
4547 KISSEI PHARMACEUTICAL CO. LTD.
7447 NAGAILEBEN CO. LTD.
4516 NIPPON SHINYAKU CO. LTD.
8086 NIPRO CORPORATION
SHL SONIC HEALTHCARE LIMITED
4543 TERUMO CORPORATION
000513 LIVZON PHARMACEUTICAL GROUP INC. CLASS A
YPSN YPSOMED HOLDING AG
109J ASPEN PHARMACARE HOLDINGS LIMITED
ORNBV ORION OYJ CLASS B
DIA DIASORIN S.P.A.
300142 WALVAX BIOTECHNOLOGY CO. LTD. CLASS A
MDC MEDICLINIC INTERNATIONAL PLC
VIFN VIFOR PHARMA AG
- Dave Nicoski
- Ross LaDuke
Vermilion Int'l Compass: Global Equity Strategy
Global equities nearing potential resistance Helped by support from global central banks and improving trade headlines, critical support levels have held for major global indexes and therefore our outlook remains constructive. At the same time, just because these indexes are not breaking down does not mean they are headed higher. Rather, we believe global equities remain in a state of purgatory and consolidation is likely to continue as several major indexes approach logical resistance... see c...
WBC WESTPAC BANKING CORPORATION
NAB NATIONAL AUSTRALIA BANK LIMITED
KORI KORIAN SA
RHM RHEINMETALL AG
ALO ALSTOM SA
8341 77 BANK LTD.
GEN GENMAB A/S
BEN BENDIGO & ADELAIDE BANK LTD.
AMP AMPLIFON S.P.A.
EXE.TO EXTENDICARE INC.
6436 AMANO CORPORATION
4559 ZERIA PHARMACEUTICAL CO. LTD.
EBO EBOS GROUP
CSL CSL LIMITED
CCP CREDIT CORP GROUP
4820 EM SYSTEMS CO. LTD.
4665 DUSKIN CO. LTD.
LABB GENOMMA LAB INTERNACIONAL S.A.B. DE C.V.
300015 AIER EYE HOSPITAL GROUP CO. LTD. CLASS A
7780 MENICON
6501 HITACHI LTD.
7011 MITSUBISHI HEAVY INDUSTRIES LTD.
6141 DMG MORI CO. LTD.
6641 NISSIN ELECTRIC CO. LTD.
6104 SHIBAURA MACHINE CO. LTD.
3360 SHIP HEALTHCARE HOLDINGS INC.
VBG B VBG GROUP AB SERIES B
GLPG GALAPAGOS NV
WEGE3 WEG S.A.
VIFN VIFOR PHARMA AG
NFI NFI GROUP INC.
Ford Equity International Rating and Forecast Report
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.